LCAV (MM)

WellPoint Inc. (WLP) has been working toward increasing awareness among the masses about child health.  For this, the company has collaborated with The American Academy of Pediatrics – an organization that has 60,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists.

Per the alliance, the American Academy of Pediatrics and WellPoint will chalk out a series that will educate individuals on pediatric health issues like childhood obesity, asthma and behavioral concerns. Moreover, the united body will emphasize on the significance of child well visits and immunizations in this program. These Pediatric Learning Collaboratives will be presented via webinars through 2014.

WellPoint is one of the leading health benefits companies in America and serves nearly 68 million people through its subsidiaries. The aforementioned collaboration is expected to create awareness and clarify queries regarding pediatric health among individuals and thus help WellPoint gain clients.

In other words, this program will not only educate individuals about child health but will also open up avenues for WellPoint to generate revenues. The long-term growth rate for this stock is 10.2%.

WellPoint has been actively collaborating with companies to enhance its services. Earlier this month, it collaborated with Healthways Inc. (HWAY) to offer its affiliated health plan members an access to Dr. Dean Ornish Program for Heart Disease. With the provision of this new program WellPoint aims to deliver enhanced services to its members and tap market opportunities.

WellPoint currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the healthcare sector include Aetna Inc. (AET) and LCA-Vision Inc. (LCAV). While LCA-Vision carries a Zacks Rank #1 (Strong Buy), Aetna holds a Zacks Rank #2 (Buy).

 
AETNA INC-NEW (AET): Free Stock Analysis Report
 
HEALTHWAYS INC (HWAY): Free Stock Analysis Report
 
LCA-VISION INC (LCAV): Free Stock Analysis Report
 
WELLPOINT INC (WLP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research